DUBLIN--(BUSINESS WIRE)-- Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per ordinary share. The dividend is payable on February 22, 2011, to shareholders of record on January 31, 2011.
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2010 revenue of $10.4 billion, Covidien has approximately 42,000 employees worldwide in more than 60 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.
Eric Kraus, 508-261-8305
Senior Vice President
Bruce Farmer, 508-452-4372
Coleman Lannum, CFA, 508-452-4343
KEYWORDS: Europe Ireland
INDUSTRY KEYWORDS: Health Biotechnology Medical Devices Pharmaceutical Other Health Research Medical Supplies Science